AdHER2DC vaccine(National Cancer Institute)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAdHER2DC vaccine(National Cancer Institute)

Drug Alias NameAutologous Dendritic Cell (AdHER2DC) Vaccine(National Cancer Institute)(National Cancer Institute)

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsEndometrial Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesNational Cancer Institute

China Registration ClassN/A

Develop Information

Active CompaniesNational Cancer Institute

Inactive CompaniesN/A

Active IndicationsEndometrial Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A